In phase 1, adverse events were not different between alclometasone and tacrolimus, nor were they different between tacrolimus and vehicle in phase 2.

• 在一阶段有害事件在阿氯米松和他克莫司间并无差别，二阶段他克莫司和赋形剂间也无差别。